tetano
Editor, Senior Moderator
J Clin Med
. 2023 Aug 11;12(16):5224.
doi: 10.3390/jcm12165224. Unraveling Acute and Post-COVID Cytokine Patterns to Anticipate Future Challenges
Makhabbat Bekbossynova[SUP] 1 [/SUP], Ainur Tauekelova[SUP] 1 [/SUP], Aliya Sailybayeva[SUP] 1 [/SUP], Samat Kozhakhmetov[SUP] 2 [/SUP], Karakoz Mussabay[SUP] 3 [/SUP], Laura Chulenbayeva[SUP] 2 [/SUP], Alibek Kossumov[SUP] 2 [/SUP], Zhanagul Khassenbekova[SUP] 4 [/SUP], Elizaveta Vinogradova[SUP] 2 [/SUP], Almagul Kushugulova[SUP] 1 2 5 [/SUP]
Affiliations
The aims of this study were to analyze cytokine profiles in patients with COVID-19, gain insights into the immune response during acute infection, identify cytokines associated with disease severity and post-COVID complications, and explore potential biomarkers for prognosis and therapeutic targets. Using a multiplex analysis, we studied the cytokine pattern in 294 acute COVID-19 and post-COVID patients with varying severities of infection. Our findings revealed that disease severity was associated with elevated levels of IL-15, IL-8, and fractalkine. Severe/extremely severe forms in comparison with mild/moderate disease were associated with MCP-1, IFNa2, IL-7, IL-15, EGF, IP-10, IL-8, Eotaxin, FGF-2, GROa, sCD40L, and IL-10. The key cytokines of post-COVID are FGF-2, VEGF-A, EGF, IL-12(p70), IL-13, and IL-6. By the sixth month after recovering from a coronavirus infection, regardless of disease severity, some patients may develop complications such as arterial hypertension, type 2 diabetes mellitus, glucose intolerance, thyrotoxicosis, atherosclerosis, and rapid progression of previously diagnosed conditions. Each complication is characterized by distinct cytokine profiles. Importantly, these complications can also be predicted during the acute phase of the coronavirus infection. Understanding cytokine patterns can aid in predicting disease progression, identifying high-risk patients, and developing targeted interventions to improve the outcomes of COVID-19.
Keywords: COVID-19; PASC; SARS-CoV-2; cytokines; post-COVID.
. 2023 Aug 11;12(16):5224.
doi: 10.3390/jcm12165224. Unraveling Acute and Post-COVID Cytokine Patterns to Anticipate Future Challenges
Makhabbat Bekbossynova[SUP] 1 [/SUP], Ainur Tauekelova[SUP] 1 [/SUP], Aliya Sailybayeva[SUP] 1 [/SUP], Samat Kozhakhmetov[SUP] 2 [/SUP], Karakoz Mussabay[SUP] 3 [/SUP], Laura Chulenbayeva[SUP] 2 [/SUP], Alibek Kossumov[SUP] 2 [/SUP], Zhanagul Khassenbekova[SUP] 4 [/SUP], Elizaveta Vinogradova[SUP] 2 [/SUP], Almagul Kushugulova[SUP] 1 2 5 [/SUP]
Affiliations
- PMID: 37629267
- PMCID: PMC10455949
- DOI: 10.3390/jcm12165224
The aims of this study were to analyze cytokine profiles in patients with COVID-19, gain insights into the immune response during acute infection, identify cytokines associated with disease severity and post-COVID complications, and explore potential biomarkers for prognosis and therapeutic targets. Using a multiplex analysis, we studied the cytokine pattern in 294 acute COVID-19 and post-COVID patients with varying severities of infection. Our findings revealed that disease severity was associated with elevated levels of IL-15, IL-8, and fractalkine. Severe/extremely severe forms in comparison with mild/moderate disease were associated with MCP-1, IFNa2, IL-7, IL-15, EGF, IP-10, IL-8, Eotaxin, FGF-2, GROa, sCD40L, and IL-10. The key cytokines of post-COVID are FGF-2, VEGF-A, EGF, IL-12(p70), IL-13, and IL-6. By the sixth month after recovering from a coronavirus infection, regardless of disease severity, some patients may develop complications such as arterial hypertension, type 2 diabetes mellitus, glucose intolerance, thyrotoxicosis, atherosclerosis, and rapid progression of previously diagnosed conditions. Each complication is characterized by distinct cytokine profiles. Importantly, these complications can also be predicted during the acute phase of the coronavirus infection. Understanding cytokine patterns can aid in predicting disease progression, identifying high-risk patients, and developing targeted interventions to improve the outcomes of COVID-19.
Keywords: COVID-19; PASC; SARS-CoV-2; cytokines; post-COVID.